BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37832390)

  • 1. Aberrant methylation scanning by quantitative DNA melting analysis with hybridization probes as exemplified by liquid biopsy of SEPT9 and HIST1H4F in colorectal cancer.
    Botezatu IV; Kondratova VN; Stroganova AM; Dranko SL; Lichtenstein AV
    Clin Chim Acta; 2023 Nov; 551():117591. PubMed ID: 37832390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric mutant-enriched polymerase chain reaction and quantitative DNA melting analysis of KRAS mutation in colorectal cancer.
    Botezatu IV; Kondratova VN; Shelepov VP; Mazurenko NN; Tsyganova IV; Susova OY; Lichtenstein AV
    Anal Biochem; 2020 Feb; 590():113517. PubMed ID: 31782995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients.
    Wang D; O'Rourke D; Sanchez-Garcia JF; Cai T; Scheuenpflug J; Feng Z
    BMC Cancer; 2021 Jul; 21(1):797. PubMed ID: 34243735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of DNA methylation by melt curve analysis.
    Smith E; Jones ME; Drew PA
    BMC Cancer; 2009 Apr; 9():123. PubMed ID: 19393074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A First Step to a Biomarker of Curative Surgery in Colorectal Cancer by Liquid Biopsy of Methylated Septin 9 Gene.
    Leon Arellano M; García-Arranz M; Ruiz R; Olivera R; Magallares S; Olmedillas-Lopez S; Valdes-Sanchez T; Guadalajara H; García-Olmo D
    Dis Markers; 2020; 2020():9761406. PubMed ID: 32566042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLAM-MS: Mutation scanning of stem-loop amplicons with TaqMan probes by quantitative DNA melting analysis.
    Kondratova VN; Botezatu IV; Shelepov VP; Lichtenstein AV
    Sci Rep; 2020 Mar; 10(1):5476. PubMed ID: 32214156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNA methylation levels of
    Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-tube PCR methods for locus-specific DNA methylation analysis.
    Candiloro IL; Mikeska T; Dobrovic A
    Methods Mol Biol; 2011; 791():55-71. PubMed ID: 21913071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.
    Pulverer W; Kruusmaa K; Schönthaler S; Huber J; Bitenc M; Bachleitner-Hofmann T; Bhangu JS; Oehler R; Egger G; Weinhäusel A
    Curr Issues Mol Biol; 2021 Oct; 43(3):1419-1435. PubMed ID: 34698107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island.
    Wasserkort R; Kalmar A; Valcz G; Spisak S; Krispin M; Toth K; Tulassay Z; Sledziewski AZ; Molnar B
    BMC Cancer; 2013 Aug; 13():398. PubMed ID: 23988185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
    Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
    Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High methylation of the SEPT9 gene in Chinese colorectal cancer patients.
    Su XL; Wang YF; Li SJ; Zhang F; Cui HW
    Genet Mol Res; 2014 Jan; 13(2):2513-20. PubMed ID: 24535900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation analysis of histone 4-related gene HIST1H4F and its effect on gene expression in bladder cancer.
    Varol N; Keles İ; Yildiz H; Karaosmanoglu C; Karalar M; Zengin K; Sarici H; Tokyol C
    Gene; 2023 May; 866():147352. PubMed ID: 36898511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer.
    He Q; Chen HY; Bai EQ; Luo YX; Fu RJ; He YS; Jiang J; Wang HQ
    Cancer Genet Cytogenet; 2010 Oct; 202(1):1-10. PubMed ID: 20804913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
    Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
    Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.
    Bacolod MD; Mirza AH; Huang J; Giardina SF; Feinberg PB; Soper SA; Barany F
    J Mol Diagn; 2020 Jul; 22(7):885-900. PubMed ID: 32407802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship of DNMT3b expression and SEPT9 methylation in theprogression of colorectal carcinogenesis].
    He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
    [No Abstract]   [Full Text] [Related]  

  • 20. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.